STOP T1D: Screen TO Prevent Type 1 Diabetes


Marian Rewers MD, PhD
Professor of Pediatrics & Medicine
Richard S. Abrams Endowed Chair
Executive Director, Barbara Davis Center for Diabetes
Aurora, CO

Brigitte Frohnert MD, PhD
Associate Professor of Pediatrics
Barbara Davis Center for Diabetes
University of Colorado
Anschutz Medical Campus
Aurora, CO


*ALL* faculty from:
Barbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, CO

Kimber Simmons, MD, MPH, Associate Professor of Pediatrics

Holly O’Donnell, PhD, Assistant Professor of Pediatrics

Cristy Geno Rasmussen, MPH, PhD, Assistant Professor of Pediatrics

Patricia Gesualdo, RN, MSPH, Senior Research Instructor

Hali Broncucia, MA, Research Instructor

Rachel Karban, MPH, STOP T1D Program Coordinator

Kathleen Waugh, MS, Senior Research Instructor

Kimberly Bautista, MPH, Research Instructor

Andrea Steck, MD, Professor of Pediatrics

Iman Taki, STOP T1D Coordinator

Flor Sepulveda, Research Services Program Manager


This online enduring program is a comprehensive educational program for health care providers (HCPs) in the United States interested in type 1 diabetes (T1D) screening and monitoring programs. This activity aims to raise awareness among HCPs and communities about the critical importance of early detection and the severe consequences of delayed diagnosis of type 1 diabetes. In addition, it will educate and empower HCPs and healthcare organizations with the knowledge, competence, and tools necessary for effective screening, age-specific monitoring practices, and timely diagnosis.


This activity is designed to meet the educational needs of HCPs such as physicians, nurses, dieticians, and other advanced practitioners who care for children and adults with and without type 1 diabetes.


Upon completion of the activity, HCPs will have improved ability to:

  • Understand the significance of early detection and intervention for T1D.
  • Be familiar with islet autoimmunity screening methods.
  • Explain the process of positive screening result confirmation.
  • Develop effective strategies for result notification, ensuring clarity and patient understanding.
  • Be familiar with monitoring protocols to track high-risk individuals with positive screening results.
  • Recognize the psychosocial impact of screening and monitoring on the patient and family.
  • Discuss the role of clinical trials and FDA-approved interventions in delaying onset of symptomatic T1D.
  • Collaborate with interdisciplinary teams to provide comprehensive care to individuals at high-risk of developing T1D.
  • Identify the key components of healthcare organizations required for effective pre-symptomatic diabetes screening and monitoring.
  • Describe screening strategies for relevant demographic groups.


In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Med Learning Group designates this enduring activity for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.


Med Learning Group designates this activity for a maximum of up to 2.5 ANCC contact hours.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Faculty Member Disclosures
Marian Rewers, MD, PhD Discloses that he has received consulting fees from Janssen, ProventionBio, and Sanofi. He has provided contracted research for Sanofi.
Brigitte Frohnert, MD, PhD Discloses that she has received grant funding from Sanofi.
Kimber Simmons, MD Discloses that she has received consulting fees and provided contracted research for Provention Bio, a Sanofi company.
Holly O’Donnell, PhD Discloses that she has received consulting fees and honoraria for speaking from Sanofi.
Cristy Geno Rasmussen, MPH, PhD Discloses that she has received consulting fees from Sanofi.
Patricia Gesualdo, RN, MSPH Has nothing to disclose
Hali Broncucia, MA Has nothing to disclose.
Rachel Karban, MPH Has nothing to disclose. 
Kathleen Waugh, MS Has nothing to disclose. 
Kimberly Bautista, MPH Discloses that she has received consulting fees from Sanofi. 
Andrea Steck, MD  Discloses that she has provided contracted research for Sanofi and Dompé farmaceutici. 
Iman Taki  Has nothing to disclose.
Flor Sepulveda Has nothing to disclose.

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

  • Shpetim Karandrea, Ph.D., Medical Director for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.


Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.


There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.


Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at


Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: June 06, 2024
EXPIRATION DATE: June 06, 2026

Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal:

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.